Works matching DE "PROSTATE tumors treatment"
Results: 1235
Mechanisms of Immunotherapy Resistance in mCRPC: Identifying the Enemy on the Visceral Metastatic Battlefield.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 986
- By:
- Publication type:
- Article
Visceral Metastases in Prostate Cancer: An Underestimated and Understudied Subgroup.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 980, doi. 10.46883/onc.2014.2811.0980
- By:
- Publication type:
- Article
Visceral Metastases and Prostate Cancer Treatment: 'Die Hard,' 'Tough Neighborhoods,' or 'Evil Humors'?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 974
- By:
- Publication type:
- Article
Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? No, Focal Therapy Provides a False Sense of Security and No Proven Benefits.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 951
- By:
- Publication type:
- Article
Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 950
- By:
- Publication type:
- Article
The Bifunctional Role of Steroid Hormones: Implications for Therapy in Prostate Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 5, p. 397
- By:
- Publication type:
- Article
Friend or Foe: The Bifunctional Role of Steroid Hormones in Prostate Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 5, p. 408
- By:
- Publication type:
- Article
Radium-223 vs EBRT for Multiple Painful Bone Metastases: Is Less More?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 297
- By:
- Publication type:
- Article
Radium-223 vs EBRT for Multiple Painful Bone Metastases: The Data Favor Radium-223.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 296
- By:
- Publication type:
- Article
Active Surveillance for African-American Men With Prostate Cancer: Of Course!
- Published in:
- Oncology (08909091), 2014, v. 28, n. 1, p. 82
- By:
- Publication type:
- Article
Active Surveillance for African-American Men With Prostate Cancer: Proceed With Caution.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 1, p. 83
- By:
- Publication type:
- Article
Gleason 6 Prostate Cancer: Serious Malignancy or Toothless Lion?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 1, p. 16
- By:
- Publication type:
- Article
Treating Prostate Cancer: Where Do We Draw the Line?
- Published in:
- 2014
- By:
- Publication type:
- Opinion
N+, M0 Prostate Cancer: Local Therapy for Systemic Disease.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 661
- By:
- Publication type:
- Article
Lymph Node Positive Prostate Cancer: The Benefit of Local Therapy.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 655
- By:
- Publication type:
- Article
Remembering Old Lessons in Prostate Cancer: Avoiding Errors 'in PARPituity'.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 595
- By:
- Publication type:
- Article
Surveillance for Prostate Cancer: Are the Proceduralists Running Amok?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 6, p. 1
- By:
- Publication type:
- Article
Focal Therapy of Prostate Cancer-The Challenge.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 1, p. 70
- By:
- Publication type:
- Article
Focal Therapy: A New Active Surveillance Tool?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 1, p. 70
- By:
- Publication type:
- Article
Evolution of the Concept of Focal Therapy for Prostate Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 1, p. 64
- By:
- Publication type:
- Article
Prostate Cancer: What Did We Learn From the 2012 Annual Scientific Meeting of ASCO?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 12, p. 1216
- By:
- Publication type:
- Article
Alpha Particles as Radiopharmaceuticals in the Treatment of Bone Metastases: Mechanism of Action of Radium-223 Chloride (Alpharadin) and Radiation Protection.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 4, p. 330
- By:
- Publication type:
- Article
Managing CRPC: Improving Symptoms, Survival, or Both?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 14, p. 1387
- By:
- Publication type:
- Article
Prostate Cancer Immunotherapy: the Role for Sipuleucel-T and Other Immunologic Approaches.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 3, p. 261
- By:
- Publication type:
- Article
Putting Provenge in Perspective.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 3, p. 255
- By:
- Publication type:
- Article
Dendreon vs CMS: Why the Provenge Coverage Controversy Is Bigger Than Just One Product.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 10, p. 881
- By:
- Publication type:
- Article
Metabolic Syndrome After Hormone-Modifying Therapy: Risks Associated With Antineoplastic Therapy.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 839
- By:
- Publication type:
- Article
The Role, Timing, and Clinical Use of ADT in Prostate Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 809
- By:
- Publication type:
- Article
Androgen Deprivation Therapy in High-Risk Prostate Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 806
- By:
- Publication type:
- Article
Cardiovascular Risk Associated With Androgen Deprivation Therapy.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 799
- By:
- Publication type:
- Article
Interest grows for focal therapy in treating prostate cancer.
- Published in:
- 2021
- Publication type:
- Interview
Emerging Treatment Options for the Management of Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Urology Times, 2021, v. 49, n. 9, p. 33
- By:
- Publication type:
- Article
What have been the biggest changes in the way you treat prostate cancer?
- Published in:
- 2021
- Publication type:
- Interview
UroPipeline. FDA grants breakthrough device designation to focal therapy system.
- Published in:
- Urology Times, 2021, v. 49, n. 6, p. 10
- By:
- Publication type:
- Article
High-risk disease with oligometastasis.
- Published in:
- Urology Times, 2021, v. 49, n. 4, p. 1
- Publication type:
- Article
PSMA-targeting agents will change prostate cancer diagnostics and treatment.
- Published in:
- 2021
- Publication type:
- Interview
Excitement grows for prostate cancer theranostics.
- Published in:
- Urology Times, 2021, v. 49, n. 3, p. 6
- By:
- Publication type:
- Article
ADT does not lower COVID-19 risk in men with prostate cancer.
- Published in:
- Urology Times, 2021, v. 49, n. 2, p. 8
- By:
- Publication type:
- Article
Treatment Options in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Urology Times, 2021, v. 49, n. 1, p. 20
- By:
- Publication type:
- Article
Case review: De novo metastatic CSPC in a 79-year-old man: Patient presents with gross hematuria as well as history of cerebrovascular accident.
- Published in:
- 2020
- Publication type:
- Case Study
Prostate cancer treatments have differential effect on quality of life.
- Published in:
- Urology Times, 2020, v. 48, n. 10, p. 23
- By:
- Publication type:
- Article
PSMA PET imaging triggers major changes in prostate cancer management.
- Published in:
- Urology Times, 2020, v. 48, n. 9, p. 12
- By:
- Publication type:
- Article
Analysis identifies genomic treatment targets in African American men: Findings create opportunity for precision medicine options in prostate cancer.
- Published in:
- Urology Times, 2020, v. 48, n. 8, p. 22
- By:
- Publication type:
- Article
American Urological Association meeting moves from Washington to the web.
- Published in:
- Urology Times, 2020, v. 48, n. 7, p. 32
- Publication type:
- Article
HIFU in focus.
- Published in:
- 2020
- Publication type:
- Interview
Surgery leads to better survival vs radiation from time of metastasis: Radical prostatectomy may result in lower risk of castration-resistant disease, data show.
- Published in:
- Urology Times, 2020, v. 48, n. 6, p. 13
- By:
- Publication type:
- Article
Advanced PCa: How evolving treatment approaches impact patient care: Experts highlight recent clinical data and their implications for diagnosis, treatment.
- Published in:
- Urology Times, 2020, v. 48, n. 4, p. 25
- Publication type:
- Article
Use of prostate Ca imaging modality leads to management changes: Intended management changes occur in 68% of patients undergoing <sup>68</sup>Ga-PSMA-11 PET imaging.
- Published in:
- 2020
- By:
- Publication type:
- Interview
PRACTICING IN A PROSTATE CANCER "REVOLUTION": Applying Key Insights from the PROCEED Real-World Registry to Clinical Practice.
- Published in:
- Urology Times, 2020, v. 48, n. 3, p. 48
- By:
- Publication type:
- Article
What are your thoughts on recent studies regarding AS and radiation in African-American men?
- Published in:
- Urology Times, 2020, v. 48, n. 2, p. 26
- By:
- Publication type:
- Article